.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Federal Trade Commission
Deloitte
QuintilesIMS
Argus Health
US Army
Harvard Business School
Merck
Cantor Fitzgerald
Boehringer Ingelheim

Generated: November 20, 2017

DrugPatentWatch Database Preview

PROZAC WEEKLY Drug Profile

« Back to Dashboard

What is the patent landscape for Prozac Weekly, and when can generic versions of Prozac Weekly launch?

Prozac Weekly is a drug marketed by Lilly and is included in one NDA. There are three patents protecting this drug.

This drug has fifty-eight patent family members in forty-five countries.

The generic ingredient in PROZAC WEEKLY is fluoxetine hydrochloride. There are twenty-seven drug master file entries for this compound. Seventy-three suppliers are listed for this compound. Additional details are available on the fluoxetine hydrochloride profile page.
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lilly
PROZAC WEEKLY
fluoxetine hydrochloride
CAPSULE, DELAYED REL PELLETS;ORAL021235-001Feb 26, 2001ABRXYesYes► Subscribe► SubscribeY ► Subscribe
Lilly
PROZAC WEEKLY
fluoxetine hydrochloride
CAPSULE, DELAYED REL PELLETS;ORAL021235-001Feb 26, 2001ABRXYesYes► Subscribe► SubscribeY► Subscribe
Lilly
PROZAC WEEKLY
fluoxetine hydrochloride
CAPSULE, DELAYED REL PELLETS;ORAL021235-001Feb 26, 2001ABRXYesYes► Subscribe► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: PROZAC WEEKLY

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Lilly
PROZAC WEEKLY
fluoxetine hydrochloride
CAPSULE, DELAYED REL PELLETS;ORAL021235-001Feb 26, 2001► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: PROZAC WEEKLY

Country Document Number Estimated Expiration
Finland119971► Subscribe
France2763846► Subscribe
Slovenia9800128► Subscribe
Australia726690► Subscribe
Russian Federation2164405► Subscribe
Colombia4940407► Subscribe
AustriaA93198► Subscribe
ItalyMI980908► Subscribe
Japan3210288► Subscribe
New Zealand330192► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Covington
UBS
AstraZeneca
Fish and Richardson
QuintilesIMS
Chinese Patent Office
Merck
Novartis
Farmers Insurance
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot